Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
27.86
+0.25 (0.91%)
At close: Mar 16, 2026, 4:00 PM EDT
28.10
+0.24 (0.86%)
After-hours: Mar 16, 2026, 7:34 PM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $1.61 billion as of March 16, 2026. Its market cap has decreased by -14.20% in one year.
Market Cap
1.61B
Enterprise Value
1.01B
1-Year Change
-14.20%
Ranking
Category
Stock Price
$27.86
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.61B, an increase of 249.53%. That is a compound annual growth rate of 25.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.60B | -25.90% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novavax | 1.67B |
| Generate Biomedicines | 1.67B |
| Enliven Therapeutics | 1.66B |
| Vericel | 1.65B |
| Innoviva | 1.63B |
| Agios Pharmaceuticals | 1.63B |
| Iovance Biotherapeutics | 1.63B |
| Nanobiotix | 1.60B |